science wire

Queensland has some of the highest fentanyl consumption and MDA excretion levels in the country, according to the latest report by The Australian Criminal Intelligence Commission (ACIC). The eighth report has been released on the same day as a new contract was signed between The University of Queensland and the ACIC for the delivery of The National Wastewater Drug Monitoring Program (NWDMP).

Queensland has some of the highest fentanyl consumption and MDA excretion levels in the country, according to the latest report by The Australian Criminal Intelligence Commission (ACIC). The eighth report has been released on the same day as a new contract was signed between The University of Queensland and the ACIC for the delivery of The National Wastewater Drug Monitoring Program (NWDMP).

University of Birmingham scientists have worked with partners in Guangzhou to develop new drugs that can tackle global health epidemics, which have an impact on China's rural communities. Researchers at the University of Birmingham joined forces with their counterparts at the Guangzhou Institutes of Biomedicine and Health (GIBH) to develop a promising hit for anti-Tuberculosis therapy and initiate a drug discovery effort.

UCL and Great Ormond Street Hospital (GOSH) today celebrated the opening of The Zayed Centre for Research into Rare Disease in Children, by welcoming the first patients through its doors for treatment.

Three M.F.A. students from the UCLA School of Theater, Film and Television have been awarded Alfred P. Sloan Foundation Awards, which recognize scripts that demonstrate examples of real or plausible science.

First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival for the treatment of the most common form of liver cancer Data will be submitted to

Four research teams from the Technical University of Munich (TUM) have received m4 Awards this year.

Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control

GPs should prescribe participation in communal singing activities to patients to raise self-esteem and overcome loneliness, a tuneful event at the University of Sussex was told this week. Dr Sarah Andersen, a practicing GP and former masters' student at the Brighton and Sussex Medical School , told the Singing for Wellbeing event held at the University of Sussex that academic studies indicated significant benefits if more doctors used community choirs as part of their social prescribing.

Gerd Folkers was the first head of Critical Thinking ETH (CTETH) and left an indelible mark on the initiative.

Two students from EPFL have developed a smart speaker with voice-activation technology that connects patients directly to their loved ones as well as caregivers and emergency services.

Detailed infectious virus testing shows potential for increasing organ donation in Australia, by including people previously ineligible due to increased risk of blood-borne viruses, writes Dr Karen Waller and Prof Angela Webster.

40% of patients with pemphigus vulgaris (PV) achieved sustained complete remission, without the use of steroids for 16 weeks or more, when treated with MabThera/Rituxan compared to 9.5% of pat

A new smart phone app and web portal to help oesophageal cancer patients and their carers understand and manage their journey better has been launched today by UCL, University College London Hospital (UCLH) and digital health company, Living With.

A sixth patient is receiving a new drug for Creutzfeldt-Jakob disease (CJD) developed by researchers at the Medical Research Council (MRC) Prion Unit at UCL.

In two head-to-head clinical trials, patients on Beovu (brolucizumab) achieved vision gains that were non-inferior to aflibercept at year one with longer treatment intervals in a majority of patients

Coated pill carries microneedles that deliver insulin and other drugs to the lining of the small intestine.

Older patients (= 2 years and < 5 years) achieved a mean increase of 5.9 points from baseline in HFMSE scores, nearly double the clinically meaningful threshold (at a mean duration of follo

A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.

Keith Humphreys founded the Stanford Network on Addiction Policy to help bring more science to debates over drug policy.

How do immune cells behave in the body? What happens during immunotherapy, which is designed to encourage the body's own immune system to attack a disease? To answer these questions, the European Union (EU) brings together leading experts from research and the pharmaceutical industry.

Phase III PREVENT study met 52-week primary endpoint of ASAS40, showing a sustained response in patients with non-radiographic axial spondyloarthritis (nr-axSpA)   Novartis plans FDA submission for nr-axSpA, having submitted to EMA previously.

Multiyear alliance underpins the Novartis commitment to leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish

Roche presents positive Phase III results for Tecentriq (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer IMvigor130 is the fi

Once-daily QMF149 demonstrated superior improvement in lung function versus mometasone furoate, meeting primary endpoint PALLADIUM is part of Phase III PLATINUM clinical development program, which ev

Efficacy of Alecensa (alectinib) in people identified to have ALK-positive non-small cell lung cancer using liquid biopsy is consistent with efficacy in those identified by tissue analysis in the pivotal Phase III ALEX study Roche will today announce positive results from a single-arm cohort of the Phase II/III Blood First Assay Screening Trial (BFAST), the first prospective study to use only blood-based next generation sequencing (NGS) to detec

Once-daily QVM149 demonstrated statistically significant improvement in lung function versus QMF149, meeting primary endpoint ,   IRIDIUM is largest study in Phase III PLATINUM clinical development p

Rituxan is the first and only FDA-approved treatment for paediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis These two forms of vascu

In MONALEESA-3, Kisqali plus fulvestrant achieved statistically significant overall survival benefit vs.

New real-world data from the Flatiron database supports clinical benefits of Alecensa (alectinib) across time to treatment discontinuation, real-world progression free survival and overall survival F

Phase III IMpower110 study showed Tecentriq monotherapy helped people with advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression live longer compared with chemotherapy alone Data wil

The study showed a confirmed objective response rate of 36% for people treated with the Tecentriq and Avastin combination in unresectable hepatocellular carcinoma who have not received prior systemic

Scientists from the UCLA Integrated Substance Abuse Programs will lead a $25 million study on in rural America.

This week Jane, Director of the Translational Research Office (TRO), talks about developing solutions to unmet medical needs, and new support for Early Career Researchers.